Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig H Selzman

Showing results (211-220 of 241) with videos related to

Pageof 25
Sort By:
Journal of the American Heart Association|February 14, 2025
Informing Management of Patients Developing Cardiogenic Shock at a Spoke and Being Transferred to a HubChristos P Kyriakopoulos, Iosif Taleb, Konstantinos Sideris, et al.
JACC. Basic to Translational Science|May 13, 2017
Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and ConditioningNikolaos A Diakos, Sutip Navankasattusas, E Dale Abel, et al.
Circulation. Heart Failure|June 6, 2022
Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS DatabaseChris J Kapelios, Lars H Lund, Omar Wever-Pinzon, et al.
Circulation. Heart Failure|July 25, 2024
Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on MortalityMiguel A Chavez, McHale Anderson, Christos P Kyriakopoulos, et al.
Circulation. Heart Failure|October 18, 2024
Cost-Effectiveness of a Shock Team Approach in Refractory Cardiogenic ShockIosif Taleb, Theodoros V Giannouchos, Christos P Kyriakopoulos, et al.
Circulation. Heart Failure|December 6, 2021
FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart FailureSalah Sommakia, Naredos H Almaw, Sandra H Lee, et al.
Cardiology|January 17, 2015
Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trialsArthur M Feldman, Lilin She, Dennis M McNamara, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 29, 2024
Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation DevicesMichael Yaoyao Yin, Eleni Maneta, Christos P Kyriakopoulos, et al.
Journal of Cardiothoracic and Vascular Anesthesia|February 10, 2018
Impact of Intubation Time on Survival following Coronary Artery Bypass Grafting: Insights from the Surgical Treatment for Ischemic Heart Failure (STICH) TrialNadia Bouabdallaoui, Susanna R Stevens, Torsten Doenst, et al.
Circulation. Heart Failure|May 5, 2021
Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova StagesPalak Shah, Mitchell Psotka, Iosif Taleb, et al.
Pageof 25

Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
Journal of the American Heart Association|February 14, 2025
Informing Management of Patients Developing Cardiogenic Shock at a Spoke and Being Transferred to a HubChristos P Kyriakopoulos, Iosif Taleb, Konstantinos Sideris, et al.
JACC. Basic to Translational Science|May 13, 2017
Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and ConditioningNikolaos A Diakos, Sutip Navankasattusas, E Dale Abel, et al.
Circulation. Heart Failure|June 6, 2022
Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS DatabaseChris J Kapelios, Lars H Lund, Omar Wever-Pinzon, et al.
Circulation. Heart Failure|July 25, 2024
Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on MortalityMiguel A Chavez, McHale Anderson, Christos P Kyriakopoulos, et al.
Circulation. Heart Failure|October 18, 2024
Cost-Effectiveness of a Shock Team Approach in Refractory Cardiogenic ShockIosif Taleb, Theodoros V Giannouchos, Christos P Kyriakopoulos, et al.
Circulation. Heart Failure|December 6, 2021
FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart FailureSalah Sommakia, Naredos H Almaw, Sandra H Lee, et al.
Cardiology|January 17, 2015
Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trialsArthur M Feldman, Lilin She, Dennis M McNamara, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 29, 2024
Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation DevicesMichael Yaoyao Yin, Eleni Maneta, Christos P Kyriakopoulos, et al.
Journal of Cardiothoracic and Vascular Anesthesia|February 10, 2018
Impact of Intubation Time on Survival following Coronary Artery Bypass Grafting: Insights from the Surgical Treatment for Ischemic Heart Failure (STICH) TrialNadia Bouabdallaoui, Susanna R Stevens, Torsten Doenst, et al.
Circulation. Heart Failure|May 5, 2021
Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova StagesPalak Shah, Mitchell Psotka, Iosif Taleb, et al.
Pageof 25